Survival outcomes and prognostic factors in early-stage (I–II) oral tongue cancer in female patients at K Hospital
Main Article Content
Abstract
Oral tongue cancer is one of the most common malignancies of the oral cavity. The treatment of tongue cancer is multimodal, in which surgery plays a central role, particularly in patients with stage I-II disease. This study was a retrospective–prospective analysis of 91 female patients diagnosed with stage I-II oral tongue squamous cell carcinoma who were treated at K Hospital between January 2018 and December 2024. Surgery was the primary treatment modality in all patients (100%). Surgery alone accounted for 86.8%, followed by 13.2% of surgery combined with adjuvant radiotherapy or chemoradiotherapy. The median follow-up duration was 33.5 months (range: 6 - 78 months). Disease recurrence was observed in 9.9% of patients after treatment. The 3-year overall survival (OS) and 3-year disease-free survival (DFS) rates were 96.7% and 90.6%, respectively. Histological grade, depth of invasion, and disease stage were identified as important prognostic factors. Therefore, a combination of treatment modalities should be considered to improve overall survival and disease-free survival in patients presenting with these adverse prognostic factors.
Article Details
Keywords
Tongue cancer, prognostic factors, female patients
References
2. Burus Todd, Damgacioglu Haluk, Huang Bin, et al. Recent and Projected Trends in Oral Tongue Cancer in the United States: A Demographic Shift in Case Burden as Early Onset Increases Among Females Subside. 2023;
3. Patel Sagar C, Carpenter William R, Tyree Seth, et al. Increasing Incidence of Oral Tongue Squamous Cell Carcinoma in Young White Women, Age 18 to 44 Years. Journal of Clinical Oncology. 2011/04/10 2011; 29(11): 1488-1494. doi:10.1200/JCO.2010.31.7883.
4. Shim S. J, Cha J, Koom W. S, et al. Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol. May 27 2010;5:43. doi:10.1186/1748-717x-5-43.
5. Rubin S J., Gurary E B, Qureshi M M, et al. Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion. Otolaryngol Head Neck Surg. Jan 2019; 160(1): 77-84. doi:10.1177/0194599818779907.
6. Cheng Hao-Shen, Liu Shih-An, Lin Jin-Ching. Survival outcome and prognostic factor analyses in early tongue cancer patients treated with surgery alone. Therapeutic Radiology and Oncology. 2020;4
7. Wu K, Wei J, Liu Z, et al. Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma. BMC Cancer. Jul 19 2019; 19(1): 714. doi:10.1186/s12885-019-5859-y.
8. Kim Min Jae, Ahn Kang-Min. Prognostic factors of oral squamous cell carcinoma: the importance of recurrence and pTNM stage. Maxillofacial Plastic and Reconstructive Surgery. 2024/03/04 2024; 46(1): 8. doi:10.1186/s40902-024-00410-3.